Read + Share
Amedeo Smart
Independent Medical Education
Upton R, Banuelos A, Feng D, Biswas T, et al. Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance. Proc Natl Acad Sci U S A 2021;118.PMID: 34257155
Email
LinkedIn
Facebook
Twitter
Privacy Policy